Sponsored by:
Al-Enabled Route Scouting Service Technical Brief
Small molecule active pharmaceutical ingredients (APls) are becoming more molecularly complex, resulting in formidable challenges for small and emerging biotechs.
Small molecule active pharmaceutical ingredients (APls) are becoming more molecularly complex, resulting in formidable challenges for small and emerging biotechs. Lonza's Al-Enabled Route Scouting Service is an advanced approach to retrosynthetic analysis that provides drug development partners with clinically and commercially viable synthesis pathways towards an API.
